Browsed by
Tag: longevity

Evolution Won’t Stop Aging Any Time Soon, but Medicine Might – Article by Sedeer el-Showk

Evolution Won’t Stop Aging Any Time Soon, but Medicine Might – Article by Sedeer el-Showk

Sedeer el-Showk


Editor’s Note: The U.S. Transhumanist Party publishes this article by Sedeer el-Showk, originally featured by our allies at Lifespan.io, in order to highlight the fallacious nature of many media outlets’ responses to a recent study about the “invariant rate of aging”. As Mr. el-Showk eloquently explains, this study does not refute or undermine the possibility of pursuing the reversal of biological aging, but simply suggests that this needs to be done through medical and technological means, and that without such means, overcoming the limitations of the current maximum human lifespan would not be feasible. Many of us in the longevity advocacy community have known this for a long time already, but it is important to spread accurate information to prevent an unjustified decline in public confidence in the feasibility of radical life extension.

~ Gennady Stolyarov II, Chairman, United States Transhumanist Party, July 25, 2021


Aging is not unstoppable, despite misinterpretations of the new study.

A new study [1] about the ‘invariant rate of ageing’ has led to reports that aging is unstoppable and that we cannot cheat death. However, this reporting is based on a misunderstanding of what the study actually says.

The misinterpretations

The study shows that “immortality and everlasting youth are the stuff of myths,” according to The Guardian. The article goes on to say that “an unprecedented study has now confirmed that we probably cannot slow the rate at which we get older because of biological constraints.” Other outlets published similar conclusions, with Futurism saying that the study shows “an ‘invariant rate of aging’ that won’t slow down”.

These reporters seem to have gotten tripped up on the idea of an ‘invariant rate’, which has the key implication that biological constraints determine the rate of human aging. This led to the conclusion that aging is fixed, inevitable, and immutable, but that’s not at all what the study shows, as the paper itself directly says.

What the study actually says

The study aimed to investigate the ‘invariant rate of ageing’ hypothesis, which proposes that the rate of aging is fixed within a species. The idea is that aging has evolved in concert with a suite of other traits, such as birth rate and metabolic rate, and this concerted evolution has led to the rate of aging being relatively fixed within a species.

In this context, ‘fixed’ is used as the opposite of ‘plastic’. It doesn’t mean ‘set in stone’. It means there’s relatively limited variation in this trait within a species because biological factors have a stronger effect on it than environmental factors. A good example might be the number of digits on a limb – environmental factors don’t really affect it, and there’s very little (but some) variation.

To test this hypothesis, the researchers created a statistical model of the age-specific risk of death in species from seven primate genera. They used data from various studies to set the parameters of their model, which is how they tested the amount of variation.

The model included parameters for infant and juvenile mortality, age-independent mortality, and senescent mortality. Variation in the biological rate of aging would be reflected in the senescent mortality parameter, since it captures what we normally think of as ‘aging’, while the infant and juvenile morality parameter reflects the misfortune of dying young.

The study’s first finding is that most of the gain in human lifespan so far has come from reducing mortality at younger ages. There’s also variation in the infant and juvenile mortality parameter, both between societies and at different times.

This also shows up in the relationship between life expectancy and lifespan equality. Media reports generally got this part of the study right, and you can look at the report on SciTechDaily to get more details about these findings.

Unlike the infant and juvenile mortality parameter, the senescent mortality parameter varied very little within each species. In fact, changing this parameter in their model shifted the mortality and demographic data of one species to look like another.

Changing the other parameters led to minor shifts in age distribution, but changing senescent mortality made it look like data from a different species. What this means is that within a given species, biological factors are the ultimate determinants of longevity.

Changing the environment to reduce mortality at younger ages (as we have in most parts of the world) affects demographics, increasing life expectancy and lifespan equality. However, accomplishing more than that will require tackling the evolved biological constraints on lifespan.

This study, therefore, doesn’t show that the rate of aging cannot be changed; it shows that there’s a limit to how much change can be realized without biological interventions, which is precisely the challenge that longevity research aims to overcome.

The paper itself closes on that note, though you wouldn’t know it from the way it’s been covered: “It remains to be seen if future advances in medicine can overcome the biological constraints that we have identified here, and achieve what evolution has not.”

Abstract

Is it possible to slow the rate of ageing, or do biological constraints limit its plasticity? We test the ‘invariant rate of ageing’ hypothesis, which posits that the rate of ageing is relatively fixed within species, with a collection of 39 human and nonhuman primate datasets across seven genera. We first recapitulate, in nonhuman primates, the highly regular relationship between life expectancy and lifespan equality seen in humans. We next demonstrate that variation in the rate of ageing within genera is orders of magnitude smaller than variation in pre-adult and age-independent mortality. Finally, we demonstrate that changes in the rate of ageing, but not other mortality parameters, produce striking, species-atypical changes in mortality patterns. Our results support the invariant rate of ageing hypothesis, implying biological constraints on how much the human rate of ageing can be slowed.

Conclusion

Ultimately, this wasn’t a study about longevity or the inevitability of aging. It was research to understand what affects the rate of aging – how much it results from evolved biological processes versus the effects of the environment. That’s important science not only for longevity research but also for evolutionary biology. It’s undoubtedly valuable, but unfortunately, its message has been misconstrued.

Far from showing that aging is inevitable, this research instead demonstrates that, ultimately, we’ll run out of environmental improvements and will have to turn to biological interventions to affect aging.

Literature

[1] Colchero, F. et al. The long lives of primates and the ‘invariant rate of ageing’ hypothesis. Nature Communications (2021), doi: 10.1038/s41467-021-23894-3

Sedeer el-Showk became a professional science writer after finishing a degree in biology. He also writes poetry and science fiction and fantasy, and somehow juggles an ever-growing list of hobbies from programming to knitting to gardening. Eternal curiosity and good fortune have taken him to many parts of the world, but he’s settled in Helsinki, Finland for the moment. He hopes he’ll never stop learning new things.

The U.S. Transhumanist Party Endorses Jennifer A. Huse for Mayor of Camden, New Jersey

The U.S. Transhumanist Party Endorses Jennifer A. Huse for Mayor of Camden, New Jersey

logo_bg


The U.S. Transhumanist Party is pleased to announce the endorsement of our first candidate during the 2021 election season – Jennifer A. Huse – who is running for Mayor of Camden, New Jersey. See the website for Ms. Huse’s campaign.

Our electronic vote of the members, which took place on April 23-30, 2021, led to an overwhelming endorsement of Ms. Huse’s candidacy by 91.9% of the members who cast their votes.

The vote totals are as follows:

Question: Shall the U.S. Transhumanist Party endorse the candidacy of Jennifer A. Huse for Mayor of Camden, New Jersey?

 

Watch the U.S. Transhumanist Party Officers’ interview of Jennifer A. Huse, conducted on February 15, 2021, by U.S. Transhumanist Party Chairman Gennady Stolyarov II, Director of Applied Innovation David Shumaker, and Director of Energy Issues John Kerecz.

On April 29, 2021, Jennifer Huse was interviewed by U.S. Transhumanist Party Regeneration Advisor Ira Pastor on the Progress, Potential, and Possibilities program. Watch this interview on YouTube here.

On Sunday, May 2, 2021, at 1 p.m. U.S. Pacific Time, the U.S. Transhumanist Party is holding a Virtual Enlightenment Salon with Jennifer Huse to give our members the opportunity to ask her further questions and discuss key transhumanist political issues with her. Follow the link above to watch the livestream of the Virtual Enlightenment Salon or the subsequent recording.

We hope to be able to endorse other candidates during the 2021 election season as well.  If you would like to be considered as a candidate for endorsement by the U.S. Transhumanist Party, please e-mail Chairman Gennady Stolyarov II with an expression of interest. Describe the office for which you plan to run, your background and qualifications, your platform, how it relates to the U.S. Transhumanist Party Platform, and what motivated your interest in running with the endorsement of the U.S. Transhumanist Party. Please check our Candidate Eligibility Criteria in Article VII of the U.S. Transhumanist Party Constitution.

U.S. Transhumanist Party Vote on the Question of Endorsing Jennifer A. Huse for Mayor of Camden, New Jersey

U.S. Transhumanist Party Vote on the Question of Endorsing Jennifer A. Huse for Mayor of Camden, New Jersey

logo_bg


The U.S. Transhumanist Party will hold an electronic vote of the membership for a seven-day period ending on 6:01 p.m. U.S. Pacific Time on Friday, April 30, 2020, on the question of whether to endorse Jennifer A. Huse, who is running as an independent candidate for Mayor of Camden, New Jersey, in 2021.

Registered U.S. Transhumanist Party members as of 12:01 a.m. U.S. Pacific Time on Friday, April 23, 2020, would be able to cast their ballots on this question and will be sent their ballots via e-mail.

See Jennifer Huse’s campaign page here.

Watch the U.S. Transhumanist Party Officers’ interview of Jennifer A. Huse, conducted on February 15, 2021, by U.S. Transhumanist Party Chairman Gennady Stolyarov II, Director of Applied Innovation David Shumaker, and Director of Energy Issues John Kerecz.

Highlights from Ms. Huse’s campaign website include the following (see additional issues here):

Healthy Life Extension Initiatives for All

We aim through a variety of initiatives, combined with human health services and biological sciences, to bring Camden to the top quality of health known to us at this time and to continue to progress in every possible endeavor to bring our citizens the highest and longest length of life in the world. We will explore every possible avenue through collaboration with leaders in health industries from around the country and world together with all of our valued Camden health professionals and researchers to work on this as a top priority.

We seek to provide the people of Camden with access to information, medicines, technology, and research as each develops. This includes offering transparency in health-related and all of our initiatives through new communication technologies and expansion of existing communication technologies for all people.

We aim to provide the community of Camden with the highest quality of water in the world. We firmly believe that water is life and essential to all persons’ quality of life and the quality of life of the planet itself. We will immediately undertake every possible opportunity to deliver top-quality water to all people of Camden.

We aim to collaborate with the small business owners of Camden to deliver an abundance of nutritious food to the community of Camden through Vertical Farming and other initiatives.

Please see our Food for All Initiative.

We aim to provide quality, nutritious food for the people of Camden through any initiatives we can possibly secure and in collaboration with experts from around the country and world. We aim to provide opportunities to our valuable industrial partners to participate in these efforts in order to bring them to the forefront of their industries and enhance all of our health and wellbeing.

Our administration values the health, wellbeing, and abundance for all of the people of Camden above all other things. We consider quality of life to be an essential and equal part of life extension.

One of our most immediate concerns has to do with Housing for All.

Every day that someone is without safe and secure housing, they are at risk of unnecessary sickness and death. We feel that without this basic need, the people of Camden are placed under unnecessary suffering and stress. We wish to explore every avenue to solve this issue entirely and permanently for all the people of Camden.

See our Housing for All Initiative.

We aim to help all households feel secure by having all of their utilities consistently connected so fear and stress do not cause detriment to their quality of life. We will explore all possible aid and programs throughout the entirety of our administration to make sure none of the households in Camden go without basic needs such as working utilities.

  • Parallel in U.S. Transhumanist Party Values and Platform The United States Transhumanist Party supports concerted research in effort to eradicate disease and illness that wreak havoc upon and cause death of sapient beings. We strongly advocate the increase and redirection of research funds to conduct research and experiments and to explore life, science, technology, medicine, and extraterrestrial realms to improve all sentient entities. [Article VI, Section V]

Ending The War on Drugs

The War on Drugs has repeatedly been proven to be detrimental to the health and wellbeing of people around the world. Our administration aims to work together with our local law enforcement to continue ending The War on Drugs locally in Camden, NJ. For years, our police have worked to help make Camden safer and more prosperous. We look to encourage and promote this loving, respectful, and effective way of policing throughout our beautiful city.

We look to continue exploring every possible avenue in regard to full decriminalization and legalization of all drugs found to be beneficial to human systems. We support the right to try any medication that may be able to improve the pain and suffering a person is experiencing within their own body.

We no longer want anyone to live in fear of arrest, detention, hefty legal and other fees, loss of time with loved ones, lowered quality of life, etc., simply for the choice of medicine they wish to put into their own bodies.

We no longer want persons that wish to work in industries that supply medicines to live in fear of arrest, detention, hefty legal and other fees, loss of time with loved ones, lowered quality of life, etc., or have to risk inferior medicines because of restricted access.

We wish all persons that may have been hurt by the war on drugs to be able to work in the legal industries through training incentives and employment opportunities.

We wish to expunge as many nonviolent drug charges as possible and will seek to help to the extent of our local powers in all areas. This is already being done in cities all over the country, and we will pursue all possible avenues to accomplish this. We aim to work together with others by looking into any other cases where persons from Camden may need assistance in regard to legal matters.

  • Parallel in U.S. Transhumanist Party Values and Platform Section XIV [Adopted by a vote of the members during March 26 – April 1, 2017]: The United States Transhumanist Party supports an end to the costly drug war, which is often an infringement upon the lives and liberties of innocent citizens who do not use drugs but fall victim to militant enforcement of drug prohibitions. The United States Transhumanist Party supports legalization of mild recreational drugs such as marijuana.

Participatory Governance

Our administration works for you! We would like for each and every one of the people of Camden to present us with any issues that you would like to see strategic solutions applied to. Upon being elected, we will put in as many avenues as possible for our valued residents to be able to present and possibly work on solving issues together along with our administration.

We aim to be as accessible as possible to all of the people of Camden, viewing each and every one of you and the quality of your health and life as our most important priority. We look to make sure that everyone has internet capabilities. We will seek to provide each person with online access through their home or by ensuring they have smartphone technologies available to them. Through new newsletter and paperless electronic alert systems, we will be able to inform all of the people of Camden of new grants, employment opportunities, health advances, and more. This will enable all people to be informed of our continued progress in our city.

We aim to achieve competence in all decision making together with maximum courtesy and empathy to ALL persons. We intend to initiate systems to allow for all of the people of Camden to be able to speak their concerns about the issues they and the city are facing. This will be set up through a variety of options including new contact methods in many departments, appointment scheduling, and problem-solving-related events. We are also interested in any persons who wish to help work on the issues themselves or may have ideas on how to improve the issues important to them.

  • Parallel in U.S. Transhumanist Party Values and PlatformSection XIII [Adopted by a vote of the members during March 26 – April 1, 2017]: The United States Transhumanist Party supports the involvement of intelligent laypersons in the political process to counteract and neutralize the influence of politically connected special interests and their paid representatives. The United States Transhumanist Party supports all electronic and other technologies that can inform and empower intelligent laypersons to monitor and contribute to political discussions and decisions.

Education for All

Our administration seeks to develop, together with our existing educational systems and the Center for Scientific Solutions, a path for all interested people of Camden to obtain education for as long as they wish to pursue it.

We also look to bring in the most progressive education system reforms and support for students and educators possible.

Our administration looks to work together with our valued Department of Education and educators to develop all of Camden’s educational systems together with experts from around the country and allies from around the world in every subject and field.

For more information on our Center for Scientific Solutions, click here.

  • Parallel in U.S. Transhumanist Party Values and PlatformSection XII [Adopted by a vote of the members during March 26 – April 1, 2017]: The United States Transhumanist Party holds that present and future societies should provide education systems accessible and available to all in pursuit of factual knowledge to increase intellectual acuity; promote critical thinking and logic; foster creativity; form an enlightened collective; attain health; secure the bounty of liberty for all sentient entities for our posterity; and forge new ideas, meanings, and values.The United States Transhumanist Party supports efforts to reduce the cost of education while improving its access. In particular, the United States Transhumanist Party supports freely available, open-source, methods of learning, teaching, credentialing, and cultural creation that integrate emerging technologies into every facet of the learning process. The United States Transhumanist Party primarily advocates private innovation to deliver such educational improvements, but also advocates the application of these improvements to all publicly funded educational institutions. The United States Transhumanist Party holds that every person should aspire toward intellectual, moral, and esthetic enlightenment and sophistication and should contribute toward bringing about a new Age of Reason, where the highest reaches of intellectual activity are attainable and eagerly pursued by the majority of the population.

The Center for Scientific Solutions

The future of Camden…The future of the World!

We aim for collaboration in this endeavor with award-winning city and community designers. It is one of our goals to offer new disaster-resistant residences and other designs to protect against extreme weather conditions. We will obtain opportunities by reaching out to every grant provider and organization available to develop the most advanced technological systems worldwide.

We aim to become prime examples of accessible displays of water, sewer, and electrical systems. We look to advance Camden’s air, soil, and water to optimal levels. Furthermore, we aim to create advanced school curriculum designs.

In collaboration with partners from around the world, we will test and advance solutions for improving our current social systems and introducing new technological solutions. The Center for Scientific Solutions will create an evolving social blueprint upon which we will work on all feasible and beneficial scientific solutions to the issues our city faces, while developing technologies that can also be used for other parts of the Nation and World. Our administration will work hand in hand together with the Center for Scientific Solutions to bring the highest quality of life to all residents of Camden and to serve as an example and innovator of progress throughout the nation and the world.

  • Parallel in U.S. Transhumanist Party Values and Platform Section IX [Adopted by a vote of the members during February 16-22, 2017]: The United States Transhumanist Party supports all emerging technologies that have the potential to improve the human condition – including but not limited to autonomous vehicles, electric vehicles, economical solar power, safe nuclear power, hydroelectricity, geothermal power, applications for the sharing of durable goods, artificial intelligence, biotechnology, nanotechnology, robotics, rapid transit, 3D printing, vertical farming, electronic devices to detect and respond to trauma, and beneficial genetic modification of plants, animals, and human beings.
20 Cutting-Edge Biotechnologies in Development Today – Article by Logan Thrasher Collins

20 Cutting-Edge Biotechnologies in Development Today – Article by Logan Thrasher Collins

Logan Thrasher Collins


I have compiled a list of some of today’s most exciting, cutting-edge biotechnologies! Some of these technologies are emerging, and some of them are already prevalent in a translational context.

1. CRISPR-Cas systems: revolutionary for gene editing, gene therapy, fundamental biology, diagnostics, and more.
2. Gene therapy: enables cures for genetic diseases and powerful treatments for many cancers, may eventually treat polygenic disorders, ameliorate aging, and even enhance human biology (e.g., provide radiation resistance to astronauts). Synergy with CRISPR-Cas technologies will greatly aid gene therapy.
3. DNA origami: paves the way for new nanomedicines, biocatalysts, biosensors, imaging probes, diagnostics, data storage methods, biocomputing, and more.
4. Computational protein engineering: paves the way for new nanomedicines, biocatalysts, biosensors, diagnostics, biomaterials, imaging probes, and more.
5. Immunotherapy: enables cures for many cancers, treatments for autoimmune diseases, and more.
6. Computational protein structure prediction: revolutionizes drug discovery and basic biology, synergizes with computational protein engineering.
7. Spatial transcriptomics: method for interrogation of cell and tissue biology in a holistic and multidimensional fashion to deeply understand health and disease, may lead to dramatic insights on aging, cognition, and pathology.
8. Optogenetics: powerful tool for understanding cellular physiology and neural circuits, may greatly enhance brain-machine interfacing (with the help of gene therapy).
9. Expansion microscopy: physically enlarges biological samples to multiply resolution. Making major strides in connectomics, vastly enhancing study of spatial organization of cells and tissues in general, synergizing with spatial transcriptomics.
10. Longevity medicines: pharmacological, gene therapy, and other methods of treating aging may extend human lifespan and dramatically reduce the prevalence of most aging-related diseases.
11. Bioprinting: produces replacement tissue and may enable manufacturing of replacement organs. Also greatly aids study of tissue biology and provides platforms for drug testing.
12. Organ-on-a-chip systems: may greatly reduce the need for animal models in research, helping to understand organ microenvironments and organ physiology in general, serving as platform for drug testing and discovery.
13. Organoids: may greatly reduce the need for animal models in research, helping to understand organ physiology (especially in context to 3D structure and function), serving as platforms for drug testing and discovery, contributing to understanding of cognition, aiding understanding of developmental biology.
14. Cryo-EM and cryo-ET: rivaling x-ray crystallography for solving high-resolution protein structures and is much easier than x-ray crystallography (especially for certain problematic samples), giving 3D images of cellular environments at sufficient resolution to see some macromolecular structural details, preserves sample integrity better than other methods.
15. Phage therapy: enables versatile and potent treatment of bacterial infections, may save the world from antibiotic resistance.
16. Synchrotron x-ray nanotomography: rapid 3D imaging in one or two colors, may help map brain structure much more rapidly than other methods. This could lead to superior brain-inspired AI and robotics, treatments for brain disease, and whole-brain simulations.
17. Tissue clearing with light-sheet microscopy: facilitates 3D imaging of tissues and even whole organs, leading to much better understanding of biological function, aids connectomics.
18. Predictive systems biology models: transforming vast biological datasets into parameters for large-scale simulations which give valuable insights. Some key examples are kinetic signaling network simulations, molecular dynamics simulations, and biophysical neuronal network simulations.
19. Injectable electronics: minimally invasive method of delivering brain-machine interface hardware, may lead to widespread biomedical and nonmedical adoption of brain-machine interfaces.
20. Minimal cells: may transform understanding of cellular physiology, may act as a superior biomanufacturing platform, may act as a superior platform for cell therapy, and more.
***

Logan Thrasher Collins is a U.S. Transhumanist Party member, futurist, synthetic biologist, author, and innovator. When he was 16, he invented a new antimicrobial protein, OpaL (Overexpressed protein aggregator Lipophilic). He next developed a bacterial conjugation delivery system for the gene encoding OpaL. His synthetic biology research has been published as a first-author journal article in ACS Biochemistry: “Design of a De Novo Aggregating Antimicrobial Peptide and a Bacterial Conjugation-Based Delivery System.” In addition, his synthetic biology research has been recognized at numerous venues including TEDxMileHigh, the Intel International Science and Engineering Fair (ISEF), the International BioGENEius Challenge at the BIO International Convention, and at the American Society for Microbiology General Meeting. At Intel ISEF 2014, his synthetic biology research won 1st place in microbiology and best of category in microbiology ($8,000) as well as the Dudley R. Herschbach award. The latter included a trip to take part in the Nobel Prize ceremonies via the Stockholm International Youth Science Seminar (SIYSS). As part of the honors at Intel ISEF, a minor planet was officially named Logancollins.

As the Chief Technology Officer (CTO) at Conduit Computing, Mr. Collins is leading a supercomputing project which has allowed visualization of how the constituent proteins of SARS-CoV-2 interact inside of cells to build whole viruses.

Visit Logan Thrasher Collins’s website here.

Judge, Jury and Executioner Syndrome – Article by Arin Vahanian

Judge, Jury and Executioner Syndrome – Article by Arin Vahanian

Arin Vahanian


The topic of life extension seems to bring forth strong emotions from people. While living longer and healthier is a goal that nearly all people say they have, there are critics of life extension who have become quite vociferous in their opposition to extending the human lifespan.  The truth is, living a longer and healthier life shouldn’t be controversial at all. After all, it is what we humans have been trying to do since day one.

However, when the topic turns to living a healthy life indefinitely, critics seem to come out of the woodwork, citing various reasons why humans should not live radically longer. While each of the major objections to life extension deserves its own space (and its own rebuttal), one objection, in particular, is rankling in its lack of substance – that human beings already live long enough.

As ridiculous as this objection is, we need to address it, not only because of the amount of damage it does to humanity by limiting life-extension research, but also because it causes unnecessary pain and suffering. People who present this objection have what I like to call “Judge, Jury, and Executioner Syndrome.”

I can’t imagine that people in the 14th century suffering and then dying from the Bubonic Plague at age 20 or 30 would have considered their life to have been “long enough.” In the same way, nor could I imagine that someone would actually find declining and then dying from an aging-related disease such as dementia at age 75 to be desirable.

But how long is long enough? Is it 40 years, like it used to be in 19th-century England? Or is it 82 years, as it is in modern-day Japan? Or is it 100 years?

It is difficult to answer this question, because there is no correct answer to the question.

However, rather than going down a rabbit hole, the best way to answer such critics is to ask them why they get to decide how long people should live. Of course, they have no right whatsoever to decide how long the human lifespan should be. This should end the conversation right then and there, but sadly, in some cases, it does not.

To go further, one might want to ask these critics whether they believe their parents or grandparents, if they are still alive, have lived too many years and whether they would want them to die quickly because they have already lived “long enough.” Or, even better, we should ask critics of life extension how many years they think their children should live (if they have children). Of course, no one, other than a psychopath, would wish such suffering and death upon their loved ones.

Therefore, it appears that people who oppose life extension on the basis that humans already live long enough, tend to only hold this view toward other people, and not themselves or their loved ones. This seems to me to be horribly cruel, not to mention illogical. However, we should not consider those who claim they are satisfied with the 82-year lifespan for themselves, as being nobler or more altruistic than other people. After all, they are still trying to play judge, jury, and executioner!

The argument that human beings already live long enough attacks the very core of what it means to be human. Human beings are designed to want to survive, and to continue living. Otherwise, we would have stopped trying to live longer a long time ago, and as a consequence, we would have stopped trying to find cures for diseases such as cancer, heart disease, or diabetes. The very fact that we are so dedicated to finding cures for conditions that have ravaged humanity is proof that we are dedicated to living longer and healthier. There is no rule that says that human beings can only live until 100 years old, or that they are not allowed to try to live longer.

Of course, just as no one may decide how long the human lifespan should be, neither should we force those who do not want to live longer and healthier, to live longer and healthier. This is a personal choice that everyone must make for themselves. But opponents of life extension do not have the right, nor do they have the ability, fortunately, to decide how long the human lifespan should be.

Even if there is some unalterable limit to how long a human lifespan can be, wouldn’t it be better to come to this conclusion and obtain closure after conducting medical and scientific research, rather than hastily quitting, and in the process, damning all of humanity to pain, suffering, and death, solely to satisfy a falsely held belief that humans already live long enough?

I understand that no matter what I may be arguing in this article, there will always be people who do not want to live much longer and healthier than they do now, for whatever reason. While I respect their decision to not want to extend their own life, I also ask them to respect my wishes to live longer and healthier. Surely this seems like a fair position to take.

There is absolutely no reason at all to apologize for wanting to live a healthy life indefinitely. No one should be asking, “Why do you want to live longer?” Rather, we should be asking, “How can we live longer and healthier?” This sort of inclusive, optimistic, and honest approach will go a long way toward removing some of the obstacles to life extension, thus putting humanity just a bit closer to attaining what it has been seeking since the beginning of time – to live a longer, healthier life.

Arin Vahanian is the Vice-Chairman of the U.S. Transhumanist Party. 

2021 New Year’s Message by Victor Bjoerk

2021 New Year’s Message by Victor Bjoerk

logo_bg

Victor Bjoerk


2021 has arrived, and it’s time for my yearly New Year’s message!

Since we all know how the world has been affected this year, there’s no point in mentioning the virus, but quite a few things happened for me.

At the beginning of this year and spring I was living in San Francisco and working on aging at BioAge. However, BioAge had to temporarily shut down because of COVID, but this wasn’t a big deal for me since I was able to transfer to Ichor Therapeutics in Syracuse, New York, which remained operational. So I got to work at two awesome leading biotech companies in the Longevity field, where I gained a lot of specific know-how which I am very grateful for!

I returned to Europe a few weeks ago, and shortly I’ll have some more exciting things to announce that I will be working on!

So yes, a lot of lemons were handed out this year worldwide, but I felt I did a decent job at making lemonade out of them. I’m a very positive person with a grand vision of wiping out all age-related disease within the next few decades, so that everybody can live as long as they want in a 25-year old body.

Some do not have that approach, they think “Longevity” means some slight health improvement by diet/exercise. Others study some aspect of aging because they want a PhD and some academic credentials (using aging as an excuse to refer to for that); however, this causes a generalized lack of a big-picture perspective for what’s going to work.

That is not me. I robustly and consistently keep up the interest until the mission is fully accomplished. In my personal roadmap I’ve developed for impacting aging, I emphasize the transdisciplinary scientific fields that are going to produce good outcomes (that may be hidden as, e.g.,“proteomics” rather than explicitly stated as “anti-aging”).

I also put an equal weight on the “business aspect” here, since your impact won’t be that big without the correct biotech business know-how, especially as AI and robotics wipe out the lab workers. Drug development and clinical trials are complex fields with 15-20 years from initial discovery to approved product. In addition, raising capital and advocacy to the public are as important as knowing the basic biology itself.

A lot of things in history have also been grotesquely mismanaged and squandered because of predictable human error, not because of the intrinsic difficulty of the science itself. There are a lot of golden nuggets laying around the labs in the world right now, and lots of resources and techniques are at our fingertips, but how will they be combined and implemented into an individual in order to cure them from aging? And how will this cocktail of interventions that forms the ultimate cure of aging be implemented across the world just like the efforts currently underway with the COVID vaccine?

A lot of setbacks are reversible and temporary, such as a lack of money and success or whatever people feel this year has caused them; aging is profoundly more serious.

During the year I read, as usual, many hundreds of scientific papers to keep up with the aging field, and also I have several publications I’ve produced, coming out now during 2021 (unfortunately peer-review takes time). I participated in many aging conferences, including one in Curacao, which meant a week of swimming in the tropics (how enjoyable!).

So yes, I felt I did many things well despite the challenges. Of course, things could always have been done better in retrospect, but that’s what one always says.

My New Year’s celebration this year isn’t very special because of all restrictions, but I wish you all a happy new year!

I have some typical New Year’s resolutions like getting fitter (but not motivating with all gyms and pools being closed, so some coaching is required), and of course continuing with the aging mission. So I’ll leave the question now to the reader: What have you done this year, and what good do you feel you can do for next year?

Victor Bjoerk has worked for the Gerontology Research Group, the Longevity Reporter, the Fraunhofer-Institut für Zelltherapie und Immunologie, BioAge, and Ichor Therapeutics. He has promoted awareness throughout Europe of emerging biomedical research and the efforts to reverse biological aging. In his honor the U.S. Transhumanist Party organized the Victor Run 2020 Virtual Race on June 5-7, 2020. 

Why I Hope to Be Alive at 75 – Article by Steve Hill

Why I Hope to Be Alive at 75 – Article by Steve Hill

U.S. Transhumanist Party Logo

Steve Hill


Editor’s Note: In this article, originally published on November 13, 2020, by our allies at the Life Extension Advocacy Foundation (LEAF), Steve Hill explains why the attitude of Joe Biden’s new advisor on COVID-19 strategy, Ezekiel Emanuel, is supremely counterproductive. Emanuel infamously wrote in 2014 that he hopes to die at age 75. Given that COVID-19 is a disease whose toll is greatly amplified by biological aging, Emanuel’s statements render him uniquely ill-suited  to remedy the ravages of the ongoing pandemic. Moreover, his pessimism toward what life is like at age 75 is no longer justified, in light of emerging medical advances that could enable rejuvenation and biological youthfulness for those who are in late middle age today. Perhaps, if he sees these advances become a reality in the not-too-distant future, Emanuel might change his mind regarding the desirability of longer lifespans.

~ Gennady Stolyarov II, Chairman, United States Transhumanist Party, November 17, 2020


2020 has been a strange year for a variety of reasons, but the societal changes that the COVID-19 pandemic has created are probably the strangest. However, it is perhaps even stranger that Dr. Ezekiel Emanuel has been appointed to advise Joe Biden on COVID strategy.

Emanuel is best known for writing a controversial article in the October 2014 edition of The Atlantic, headlined “Why I Hope to Die at 75”, in which he strongly rejects the desire to live beyond the age of 75 and expresses his opinion that continuing to live after such an age is meaningless.

Living too long is also a loss. It renders many of us, if not disabled, then faltering and declining, a state that may not be worse than death but is nonetheless deprived.

Needless to say, I strongly disagree with this baffling point of view and am somewhat concerned that someone who thinks this way of his own life, and presumably the lives of others, may be appointed to a position of influence for a disease whose primary risk group is the elderly. This seems almost as foolhardy as spending a vacation weekend in a caravan with Hannibal Lecter.

Emanuel listed quite a few methods by which people extend their lives and stated that they were a “valiant effort to cheat death and prolong life as long as possible,” but his response to them was, “I reject this aspiration. I think this manic desperation to endlessly extend life is misguided and potentially destructive.”

Age is the #1 risk factor for COVID

The scientific evidence clearly shows that the primary risk factor for contracting and dying from COVID-19 is age, with people over the age of 75 at particularly high risk. This is due to the decline of the immune system, which becomes increasingly weak and dysfunctional with age in a process known as immunosenescence.

Globally, the strategy has been to try to shield these vulnerable people as best as possible due to their weakened immune systems and limit their exposure to the disease while vaccines are developed.

Needless to say, I find Biden’s nomination of him to address a disease that mostly affects seniors ironic in itself, given that he thinks the lives of most people beyond 75 are pointless and that they don’t live meaningful lives and would be better off embracing death rather than desperately trying to extend them. Therefore, I hope for the sake of the older people in our society that he has rethought his priorities.

Why I hope to be alive at 75

Predictably, there is already a storm raging on social media around his appointment, so there is no purpose to adding more fuel to that fire. Instead, I am going to talk about why the future of aging could be very different to the grim picture that Emanuel paints.

At age 63, he is getting closer to the age at which he thinks life is pointless, and I believe that a large reason why he is so pessimistic about life beyond 75, whether he realizes it or not, is based on the current state of medicine. This line of reasoning does not take into account how medicine, and in particular how we treat aging could change in the next decade or two.

Current medicine does a great job at keeping people alive for longer, but they often have to live with one or more chronic diseases. Given that, I am not surprised that Emanuel is not enamored with living a long life, especially as that could entail being disabled, bed-bound, or otherwise suffering a poor quality of life as the result of debilitating age-related diseases.

Thankfully, the world healthcare strategy is slowly starting to shift to one of prevention over cure, but right now, the typical approach is to play whack-a-mole with diseases. As one pops up, it is treated, then the next, and the next, and so on. This strategy works great for infectious diseases, but it is an exercise in futility and diminishing returns when applied to the chronic diseases of aging.

However, things could be different in the not so distant future, and being 75 could see the majority of people far more fit, healthy, and vibrant than ever before in human history thanks to advances in aging research. Therapies that directly target aging could potentially make people biologically younger (in particular their immune systems) and much more able to withstand COVID-19 and other diseases.

As explained on LEAF’s What is Aging? page, aging consists of multiple processes (“hallmarks”) that gradually cause damage to organs and tissues and lead to age-related diseases. Rejuvenation biotechnology is advanced medical technology that directly addresses any of the various aging processes in order to restore tissue and organ function to a more youthful state, thereby ameliorating, delaying, or preventing age-related diseases. Let’s take a brief look at some of the promising near-future research that could bear fruit by the time Emanuel reaches 75 and perhaps change his mind.

Rejuvenating the immune system

The decline of the immune system is a key reason why the elderly are most susceptible to infectious diseases such as COVID, and there has been considerable interest in the rejuvenation of the immune system in recent years.

Dr. Greg Fahy from intervene immune has had some early success with thymus rejuvenation in a small human pilot study and demonstrated that it is possible to cause the thymus, which shrinks and loses its capacity to produce immune T cells during aging, to regrow and resume production of those cells. Dr. Fahy is now moving forward into a larger-scale study, and if the results continue to be positive, it is not hard to imagine that thymus regrowth could become a staple of helping the elderly stay healthy.

Another example of immune rejuvenation is currently being developed by Samumed, a biotechnology company that is developing drugs that target the Wnt pathway to restore it to youthful function. The Wnt pathway is a key pathway that regulates the function of our stem cells and ensures that they supply our tissues and organs with new cells to replace losses from injury, disease, and wear and tear.

If successful, this approach would allow the body to resume efficient repair of tissues, and it would replenish aged and failing tissues and organs with fresh, healthy cells supplied by the rejuvenated stem cells.

Therapeutic plasma exchange

Researchers Irina and Mike Conboy at UC Berkeley have been researching blood factors and their role in aging for over two decades. During that time, they have identified a number of factors present in aged blood that appear to regulate aging.

These factors are also present in younger people, but in typically far lower amounts, and tend to serve useful functions. However, during aging, the levels of these proteins become deregulated, and they often rise to detrimental levels and cause damage to the body, which typically involves preventing stem cells from working and tissue from regenerating.

Decades’ worth of research from the Conboy lab has shown that, in mice at least, it is possible to filter out these harmful pro-aging blood factors and bring them back down to a level similar to younger animals. When this happens, the result is rejuvenation of tissues and the reversal of some of the aspects of aging, making the mice more youthful.

This approach uses an already approved technique known as therapeutic plasma exchange to filter and calibrate these key factors and could be readily modified for human use. Should the results seen in animals translate to humans using this approach, it would have a profound effect on our health as we age and potentially delay, prevent, or even reverse some age-related diseases.

Conclusion

These are only some of the examples of why healthy life expectancy could rise significantly in the near future, and there are plenty of reasons to remain future positive. This is the future direction of medicine and healthcare that we support at Lifespan.io, a world where being 75 does not mean you are thrown on the scrap heap and where people like Emanuel will no longer feel that life has no meaning. I am confident that in such a world, being 75 would not be the burden he thinks it will be, and this is why I hope to be alive at 75.

Steve Hill serves on the Life Extension Advocacy Foundation (LEAF) Board of Directors and is the Editor-in-Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, along with attending various medical industry conferences. His work has been featured in H+ Magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep Me Prime, and New Economy Magazine. Steve has a background in project management and administration, which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.

Liz Parrish Becomes Vice-Presidential Nominee for Charlie Kam’s 2020 U.S. Presidential Campaign

Liz Parrish Becomes Vice-Presidential Nominee for Charlie Kam’s 2020 U.S. Presidential Campaign


PRESS RELEASE

FOR IMMEDIATE RELEASE

Contact: Gennady Stolyarov II
Chairman, United States Transhumanist Party
E-mail: gennadystolyarovii@gmail.com

August 21, 2020 – Charlie Kam, the candidate for President of the United States endorsed by the United States Transhumanist Party (USTP), has announced his selection of Elizabeth (Liz) Parrish as his Vice-Presidential running mate.

Elizabeth (Liz) Parrish

Remarking on his selection, Charlie Kam stated, “Elizabeth (Liz) is the embodiment of what it means to be a Transhumanist. She is the Founder and CEO of BioViva, a company committed to extending healthy lifespans using cell technologies. Liz is a humanitarian, entrepreneur, innovator, podcaster, and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach. Along with all of that, Liz is a good friend whom I’ve known for years, and I look forward to campaigning together to promote the ideas and values of the USTP!”

USTP Chairman Gennady Stolyarov II remarked that “The U.S. Transhumanist Party is honored to be represented by such an articulate, passionate, and intrepid advocate of longevity and medical science as Liz Parrish. Liz Parrish is one of the world’s leading proponents for the development of gene therapies to treat a variety of diseases, including biological aging. Anyone who follows the field of rejuvenation biotechnology knows that, in 2015, Liz Parrish became the first human to receive a combination gene therapy as ‘patient zero’ in her own experiment. This was an immensely courageous decision which showed leadership by example, led to greatly enhanced public awareness, and inspired many to advocate for this burgeoning field of research and human benefit. Liz Parrish speaks powerfully about the imperative to cure diseases and minimize the horrific suffering that many – from children to the elderly – undergo today because of various common and rare ailments. Her voice and energy will be tremendous assets to the Charlie Kam campaign and to the USTP as we spread the essential message of the feasibility and desirability of significant life extension during our lifetimes and cultivate public awareness and support for the policies and projects that could get us there.”

Liz Parrish is involved in numerous organizations and projects in addition to her role at BioViva. She is the Advocacy Advisor to the USTP and a founding member of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa-based, highly gifted persons who advance scientific discourse and discovery. The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. Liz Parrish is the founder of BioTrove Investments LLC and the BioTrove Podcasts, which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine.

Commenting on her new role as the Vice-Presidential candidate endorsed by the USTP, Liz Parrish stated, “I believe now is the right time in human history to further the transhumanist mission. Our planet, our species, and the survival of all other species are in our hands now. People are tired of division and divisiveness. Humans must convene, start a new conversation, and work toward bettering our condition and that of our planet through the transhumanist mission.”

The USTP looks forward to numerous opportunities to inform, educate, and galvanize the public in the United States and the world through the Kam-Parrish 2020 U.S. Presidential ticket. Any individual in the world who is capable of forming a political opinion and who agrees with the three Core Ideals of the USTP is welcome to join the USTP as a member for free.

“During the next ten weeks, Charlie Kam and Liz Parrish will show the world that a better future, and a better approach to political discourse, are possible and are on the horizon. They will also bring attention to the technologies and policies that will enable as many people as possible to live to see that future,” remarked Chairman Stolyarov. “Supporting the Kam-Parrish 2020 ticket is the prudent, foresighted choice for those who wish for the transhumanist vision and values to become an everyday reality for all.”

United States Transhumanist Party Announces Major Internal Reorganization and Launch of the Charlie Kam 2020 U.S. Presidential Campaign

United States Transhumanist Party Announces Major Internal Reorganization and Launch of the Charlie Kam 2020 U.S. Presidential Campaign

logo_bg


PRESS RELEASE

FOR IMMEDIATE RELEASE

Contact: Gennady Stolyarov II
Chairman, United States Transhumanist Party
E-mail:
gennadystolyarovii@gmail.com 

June 11, 2020 – The United States Transhumanist Party (USTP) is pleased to announce a major internal reorganization undertaken in the interests of advancing the transhumanist movement, improving internal efficiencies, leveraging Officer skill sets, and bringing our internal conversations and outreach to the public in closer alignment with the USTP Values and Platform. 

Highlights:

  • Charlie Kam has been endorsed as the USTP’s 2020 Presidential Candidate and promoted to USTP Director of Marketing.
  • Arin Vahanian has been promoted to USTP Vice-Chairman. 
  • (Art Ramon) Garcia, Jr., has been newly appointed as USTP Director of Visual Art.
  • Tom Ross has assumed the new position of Director of Sentient Rights Advocacy.
  • John J. Kerecz has assumed the new position of Director of Energy Issues.
  • B.J. Murphy has assumed the new position of Director of Foreign Relations.
  • Recent Foreign Ambassador appointments: Christian Meniw in Argentina and Henry Hoyos in Bolivia.
  • Daniel Yeluashvili has joined the USTP Officer team as the new Director of Longevity Outreach. 
  • A six-person USTP Social-Media Team was formed, consisting of USTP Officers Arin Vahanian, Brent Reitze, Tom Ross, Dan Elton, David Shumaker, and Daniel Yeluashvili. 

“This reorganization emphasizes the importance of maintaining a cohesive, civil, techno-optimistic, and constructive approach to the work of the U.S. Transhumanist Party during the last seven months of 2020 and beyond,” USTP Chairman Gennady Stolyarov II explained. “During an extremely difficult time for the United States and for the world, we must ensure that our organization and the broader transhumanist movement remain resilient and continue to produce inspiring output in spite of great turmoil. We must not allow the forces of that turmoil to divide us, but rather should remain a big-tent organization that is welcoming of diverse advocates of a technologically driven future, no matter which conventional political perspectives those individuals choose to espouse.”  

The USTP hereby confirms the departure of Johannon Ben Zion (J. Ben Zion) from our organization. As the USTP and several other groups combined and reorganized, Mr. Ben Zion found himself better aligned with a more directly techno-progressive platform and has opted to head that initiative, leaving his capable running-mate as the USTP’s candidate. Accordingly, the Officers of the USTP have determined to release Mr. Ben Zion from any of his roles and affiliations with the USTP, as well as from any previous endorsements by the USTP. 

In accordance with the rules of succession and as confirmed unanimously by the USTP Officers, the previously endorsed U.S. Vice-Presidential candidate, Charlie Kam, has become the USTP’s endorsed U.S. Presidential nominee. Mr. Kam has also concurrently been promoted to the role of USTP Director of Marketing, and the USTP looks forward to a variety of creative approaches to promoting the USTP brand from an individual with a long-standing history in the transhumanist movement, who has forged effective alliances with celebrities and scientists alike, while entertaining members of our community with his creative films in support of the technological Singularity and longevity research. Mr. Kam’s involvement with the recently formed Institute to Expedite the Singularity, which he co-founded, is a demonstration of his commitment to accelerating beneficial technological progress.

Charlie Kam, 2020 U.S. Presidential Nominee and Director of Marketing, United States Transhumanist Party

After the confirmation of his endorsement by the USTP, Mr. Kam released the following statement: “I am both excited and honored to be the 2020 Presidential nominee of the USTP.  I’ve been a Transhumanist for decades, having studied books by Ray Kurzweil, Richard Feynman, K. Eric Drexler, and other great thinkers. I hosted and sponsored the TransVision 2007 conference with scientist and celebrity speakers, including William Shatner. I’ve produced many films and songs on the subject, and have long believed that the human race can ‘evolve’ beyond its current physical and mental limitations by means of science and technology. The goal of my candidacy is to help spread these ideas to the benefit of all of humankind.”

Chairman Stolyarov commented on the USTP’s endorsement of Mr. Kam’s campaign, “Above all, the USTP’s Presidential nominee is a spokesperson for the ideas and goals of transhumanism, and the USTP has always sought individuals whose dedication to those ideas and goals takes precedence over any personal ambitions. Charlie Kam is a prime example of this kind of person. He has worked for decades to forge the transhumanist movement into what it is today, and he has done it out of a passion for seeing the future articulated by the great scientists and innovators whom he mentioned come to pass during our lifetimes. Charlie Kam is universally admired and respected throughout transhumanist and life-extensionist circles. I can think of no better nominee to focus the remainder of the 2020 election season on healing our community, withstanding the pandemic, and ensuring that transhumanism comes out of it healthier and more vibrant than ever before.” 

Arin Vahanian, Vice-Chairman, United States Transhumanist Party

In recognition of his dedication to the USTP and passionate advocacy of transhumanism and life extension, the USTP’s previous Director of Marketing, Arin Vahanian, has been promoted to the role of Vice-Chairman. Mr. Vahanian has worked extensively to cultivate mainstream appeal of transhumanism, necessary for our movement to become a major cultural, societal, and political influence. In response to this appointment, Mr. Vahanian stated, “Improving the human condition through advancements in science and technology is something that is very near and dear to me. Therefore, the opportunity to serve as Vice-Chairman of the USTP is a tremendous honor. I hope to repay everyone’s trust in me by doing the best I can to continue our advocacy work and spread the word about our party and our movement’s focus and dedication on improving the human condition by leveraging science and technology.”

(Art Ramon) Garcia, Jr., Director of Visual Art, United States Transhumanist Party

The USTP has also at last satisfied its goal of filling its long-vacant position of Director of Visual Art. Esthetics constitute an important part of political communication and public relations, and the addition of a talented painter and graphic designer, (Art Ramon) Garcia, Jr., will enable the USTP’s output in this area to reach new heights. Mr. Garcia’s ambitions for the future of human creativity are immense and multi-faceted. He depicts his transhumanist belief in his artwork while creating novel symbols to represent the belief within his works. He envisions becoming an immortal AI-enhanced posthuman who will one day build the largest art gallery space on Mars. Mr. Garcia’s paintings can be viewed here, and he has also contributed a multitude of concepts to the USTP’s Free Transhumanist Symbols project. 

Mr. Garcia outlined his objectives in his new position:

“As Director of Visual Art, my goal is to assist the party in all facets of artistic, visual, and creative tasks that are required of any organization wishing to present itself to a targeted audience in order to promote its goals while attracting supporters. This can include anything from graphic design and web design, which are my stronger skillsets. However, I’m open to learning skills in the area of video and audio production.”

“In addition, I also have connections within the art community which can be leveraged for tasks that may be beyond my skill level.”

“Secondly, as a creative brainstormer, my goal is to present ideas that may have been overlooked or not considered by the Party, as well as to identify caveats not foreseen by others, which can assist with decision making and guidance of the Party. As a self-identifying transhumanist for almost 5 years, who constantly read on the subject, numerous ideas have sparked in my head, but I had nowhere to apply them.”

“Third, my personal objective is to be fully informed of all facets of transhumanist research, direction, technology, and culture, as I decide how to evolve my current form into the immortal posthuman cybernetic being I wish to become. In this new form, I’ll be able to achieve self-actualization as an artist without the worry of a decaying body, since at present most of my time is spent working for monetary compensation in order to fulfill basic needs, depriving me of valuable artistic improvement and creation of artworks.”

Tom Ross, Director of Sentient Rights Advocacy, United States Transhumanist Party

Tom Ross, who has capably served as Director of Media Production for the USTP since early 2019 and created numerous engaging, high-quality graphics and videos for our organization, has stepped into a newly formed position, Director of Sentient Rights Advocacy. This position will apply the provisions of the Transhumanist Bill of Rights, Version 3.0, to the extent achievable in the contemporary world, and work for the protection of sentient entities whose rights are under threat, identifying ways to creatively use technology and applied rationality to resolve long-standing societal problems that endanger the rights of sentient entities.  “I joined the USTP because it has real-world ideas to fight Modern Slavery and includes definitions of and proactive solutions for achieving Sentient Rights,” Mr. Ross stated. “This is the central theme of my work as an author and as an A.I. advocate, so I am extremely excited to be named Director of Sentient Rights Advocacy. As such, I look forward to further publicizing the USTP’s definitions, aligning with Sentient Rights groups of all levels, and co-producing awareness campaigns to secure these rights well into the future.”

John J. Kerecz, Director of Energy Issues, United States Transhumanist Party

John J. Kerecz, a unifying presence within the USTP’s ranks, has assumed the new role of Director of Energy Issues to capitalize on his expertise in energy assurance and resiliency. This position will focus on energy policy and innovation. As energy supports the entire infrastructure of technological development and contemporary life more generally, Mr. Kerecz’s expertise in this realm will inform the USTP’s advocacy regarding how our civilization could always cleanly and affordably maintain sufficient energy to develop the advances we need to fundamentally improve the human condition. Mr. Kerecz expressed his support for the USTP’s goals and stated, “I believe in the future of tomorrow and that future is what we are making happen through the USTP.”

B.J. Murphy, Director of Foreign Relations, United States Transhumanist Party

B.J. Murphy, who originated and has capably managed the USTP Foreign Ambassador Program, has formalized his role in this area by stepping into the newly created position of Director of Foreign Relations. Mr. Murphy will continue his present duties in that role, and the USTP looks forward to expanding our international reach through active Foreign Ambassadors and Allied Members. The USTP has added multiple Foreign Ambassadors in 2020. Since the last announcements of such additions were made, the USTP welcomed Dr. Christian Meniw as the new Foreign Ambassador in Argentina and Henry Hoyos as the new Foreign Ambassador in Bolivia. Dr. Meniw currently has two projects related to the future of Latin America. The first project is to provide a new path forward through the economic and political landscape through the development of megalopolis, and the second one is called Society 5.0+, which aims to establish the democratization and decentralization of emerging technology. Mr. Hoyos has expertise in building business models in telecommunications, cybersecurity, Smart City development, and digital transformation, and is currently developing biosecurity, telemedicine, and tele-education business models based on emerging neuroscience and digitalization.

Daniel Yeluashvili, Director of Longevity Outreach, United States Transhumanist Party

A crucial initiative on which the USTP has been collaborating with Dr. Meniw has been our widely publicized Proposal for Argentina to Declare a Mandate for Longer Life Spans and the Reasonable Treatment of Aging as an Ailment, which has advanced to increasing prominence in discussions with Argentine officials. USTP member and Climate Advisor Daniel Yeluashvili has been instrumental in spearheading and sustaining this initiative, and the USTP has recognized Mr. Yeluashvili’s efforts in this regard by designating him as the USTP’s new Director of Longevity Outreach. Mr. Yeluashvili also has considerable expertise on climate issues and has provided thoughtful input into the USTP’s Platform proposals since the onset of member voting within the USTP 3.5 years ago.

Many other USTP Officers will continue in their current roles and collaborate with the realigned Officer positions described above. Officers continuing in their current positions are Chairman Gennady Stolyarov II, Secretary Pavel Ilin, Vice-Secretary Caeus H. Antony, Director of Admissions and Public Relations Dinorah Delfin, Director of Applied Innovation David Shumaker, Director of Publication Brent Logan Reitze, Director of Scholarship Dan Elton, and Legislative Director Justin Waters. “This reorganization is intended to be a set of changes to harness various incremental improvements, but it should not be seen as a disruptive or revolutionary type of change,” Chairman Stolyarov explained. “Everything good about how the USTP has previously operated will be retained and amplified. This set of changes is intended to preserve all that we have accomplished during our first 5.5 years as an organization, while setting the stage for further progress. At this time, steady leadership, incremental improvement, and preservation of our achievements and values are essential to steer our organization amidst a world in chaos.”  

The USTP Officers have also made active efforts to enhance the regularity and quality of the USTP’s social-media presence. In the past, the USTP had Director of Social Media and Director of Media Production positions; however, the USTP Officers have recognized that the responsibilities of these roles pertain to an extremely broad array of tasks and areas of involvement. Accordingly, distributing the workload of social-media promotion and content creation to a six-person team was decided to be more effective from the standpoint of attending to the wide variety of the USTP’s social-media activities and coordinating on the production and distribution of USTP-endorsed content. The members of the USTP Social-Media Team also hold other Officer roles in our organization. They are Arin Vahanian, Vice-Chairman, Dan Elton, Director of Scholarship, Brent Logan Reitze, Director of Publication, Tom Ross, Director of Sentient Rights Advocacy, David Shumaker, Director of Applied Innovation, and Daniel Yeluashvili, Director of Longevity Outreach. “Each of the six Social-Media Team members has a skill set that is distinctively suited to this realm,” explained USTP Chairman Stolyarov. “Even more importantly, each of them has a thoughtful and rational demeanor that allows for sincere and civil communication to transpire in determining what content to create and share. If these six individuals can agree on a decision to distribute any content, we can be assured that such content will be of high quality and reflective of the USTP’s principles and objectives.” The USTP has already begun more active social-media outreach efforts, with Director of Scholarship Dan Elton greatly amplifying the frequency of our Twitter posts. Through regular, high-quality social-media offerings, the USTP hopes to expand its reach and the rate of growth of its membership, and the USTP Officers look forward to the Social-Media Team’s work in advancing these aims.

The USTP takes the opportunity offered by this reorganization to reaffirm its commitment to the pursuit of superlongevity, the philosophy of transhumanism, and its techno-optimistic vision of a future where historical and contemporary human limitations are overcome and longer, better lives are achieved for all sentient entities. To our members, our Advisors, our state-level affiliates, our Allied Organizations, and to the transhumanist and life-extensionist community more broadly, we expect this reorganization to enable a more high-minded, inclusive, resilient, and constructive expression of the USTP’s Core Ideals and aspirations – a dedication to our founding documents and to upholding the decisions of our members, while preventing the divisions of mainstream politics from imposing themselves upon our interactions and endeavors. We look forward to what the Kam 2020 campaign and the realigned Officer team can achieve. 


Results of the Victor Run 2020 Virtual Race – June 5-7, 2020

Results of the Victor Run 2020 Virtual Race – June 5-7, 2020

logo_bg

Gennady Stolyarov II


The United States Transhumanist Party (USTP) is pleased to announce that its first-ever virtual running race, the Victor Run 2020, has come to a successful conclusion with 29 runners participating and $1,290 raised to help longevity researcher Victor Bjoerk relocate to a paid research position with Ichor Therapeutics in Syracuse, New York. This virtual race has inspired numerous runners to undertake bold and challenging feats during the weekend of June 5-7, 2020, for the advancement of longevity, health, and fitness. Victor Bjoerk himself participated in the race and ran his first marathon, self-supported – a great achievement! Congratulations to Victor and to all of the runners for taking part in this experiment. All participants will be rewarded with custom finisher medals, and there will be additional awards to the top 3 finishers by gender. Medals are currently in production, and it is expected that they will be sent to participants in late June 2020.

This race embodied the goal of indefinite longevity by setting no limit on how long participants could run. Indeed, it was a race that rewarded the most persistent! The scoring for the race relied on a unique metric that combined distance, speed, and elevation gain in a manner that gave any participant the opportunity to win with sufficient determination.

We congratulate the top 3 finishers in each gender category:

First-Place Male and Overall – David Ravarino
Second-Place Male and Overall – Chris Badolato
Third-Place Male and Overall – Bill Andrews

First-Place Female – Jess Haltom
Second-Place Female – Carla Katz
Third-Place Female – Karen Carlson

Overall Race Standings

Top 3 Finishers – Overall/Male and Female

Male Finishers

Female Finishers